Cytomegalovirus Serostatus and Functional Impairment in Liver Transplant Recipients in the Current Era
- PMID: 34452384
- PMCID: PMC8402920
- DOI: 10.3390/v13081519
Cytomegalovirus Serostatus and Functional Impairment in Liver Transplant Recipients in the Current Era
Abstract
Background: Whether donor (D+) or recipient (R+) cytomegalovirus (CMV) seropositivity is associated with functional impairment in liver transplant recipients is not known.
Methods: Patients included adult liver transplant recipients in the Organ Procurement and Transplantation Network database transplanted over a five-year period from 1 January 2014-31 December 2018. Functional status in the database was assessed using Karnofsky performance scale. A logistic regression model that controlled for potential confounders was used to examine the association of CMV serostatus and functional status. Variables significantly associated with functional status (p < 0.05) were then used to develop propensity score and propensity score matched analysis was conducted where each patient was compared with a matched-control with the same propensity score.
Results: Among 30,267 adult liver transplant recipients, D+ or R+ patients had significantly lower functional status at last follow-up than the D-R- cohort (OR 0.88, 95% CI 0.80-0.96, p = 0.007). In propensity score matched model, D+ or R+ patients had significantly lower functional status than matched-controls (p = 0.009). D+ or R+ CMV serostatus (p = 0.018) and low functional level (p < 0.001) were also independently associated with infections as cause-of-death.
Conclusions: D+ or R+ liver transplant recipients had lower functional status and higher risk of deaths due to infections. Future studies are warranted to examine the mechanistic basis of these findings in the setting of transplantation.
Keywords: cytomegalovirus; functional status; outcomes; transplant.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.Transpl Infect Dis. 2019 Feb;21(1):e13015. doi: 10.1111/tid.13015. Epub 2018 Nov 19. Transpl Infect Dis. 2019. PMID: 30358023
-
Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant Recipients.Liver Transpl. 2021 Sep;27(9):1302-1311. doi: 10.1002/lt.26045. Epub 2021 Jul 31. Liver Transpl. 2021. PMID: 33687777 Free PMC article.
-
Factors associated with the development of cytomegalovirus infection following solid organ transplantation.Scand J Infect Dis. 2011 May;43(5):360-5. doi: 10.3109/00365548.2010.549836. Epub 2011 Feb 9. Scand J Infect Dis. 2011. PMID: 21306196
-
Impact of donor and recipient cytomegalovirus serology on long-term survival of lung transplant recipients.Transpl Infect Dis. 2018 Oct;20(5):e12964. doi: 10.1111/tid.12964. Epub 2018 Jul 20. Transpl Infect Dis. 2018. PMID: 29981174
-
Cytomegalovirus infection after liver transplantation: current concepts and challenges.World J Gastroenterol. 2008 Aug 21;14(31):4849-60. doi: 10.3748/wjg.14.4849. World J Gastroenterol. 2008. PMID: 18756591 Free PMC article. Review.
References
-
- 2018 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 2007–2018. [(accessed on 8 July 2021)]; Available online: https://srtr.transplant.hrsa.gov/annual_reports/2018/Liver.aspx.
-
- Wang G.C., Kao W.H.L., Murakami P., Xue Q.-L., Chiou R.B., Detrick B., McDyer J.F., Semba R.D., Casolaro V., Walston J.D., et al. Cytomegalovirus infection and the risk of mortality and frailty in older women: A prospective observational cohort study. Am. J. Epidemiol. 2010;171:1144–1152. doi: 10.1093/aje/kwq062. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
